Pasithea Therapeutics Corp.
KTTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001841330
Other share classesKTTAW
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
25
- +4 vs. Q1 2026
- Total value $8.66M
Superinvestors holding KTTA
0
- None of the superinvestors held KTTA at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by KTTA insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Jun 17, 2026 | Coastlands Capital LP10% Owner | PPurchaseCommon Stock | +100K | $0.53 | +$53K | 3.84M | +2.7% | SEC |
| Dec 1, 2025 | Nov 28, 2025 | STEINMAN LAWRENCEDirector | PPurchaseCommon Stock | +133.33K | $0.75 | +$100K | 199.69K | +200.9% | SEC |
| Dec 1, 2025 | Nov 28, 2025 | Marques TiagoChief Executive Officer | PPurchaseCommon Stock | +33.33K | $0.75 | +$25K | 73.33K | +83.3% | SEC |
| Dec 1, 2025 | Nov 28, 2025 | Dumesnil SimonDirector | PPurchaseCommon Stock | +33.33K | $0.75 | +$25K | 35.83K | +1,333.3% | SEC |
| May 14, 2025 | May 12, 2025 | Marques TiagoChief Executive Officer | SSaleCommon Stock | −960 | $0.83 | −$796.8 | 40K | −2.3% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in KTTA at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cable Car Capital LLC | 3,000,000 | $1.55M | 0.03% | +1,793,621+148.7% | Added |
| Stonepine Capital Management, LLC | 2,201,468 | $1.13M | 0.86% | +1,370,167+164.8% | Added |
| Jupiter Topco LLC | 2,100,000 | $1.09M | 0.00% | +2,100,000 | New |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,100,000 | $1.08M | 0.00% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,050,000 | $1.06M | 0.10% | +2,050,000 | New |